Closing the Mortality Gap: RA and Heart Disease
This week on HealthCentral, I'm looking at good news about Biologics and the systemic impact of RA:
"It’s called the mortality gap. And none of us like to think about it.
The average life expectancy of people with RA is 10 years less than
the general population. RA is a systemic disease that affects not just
our joints, but also our internal organs. The mortality gap exists
because the systemic inflammation of RA leads to a higher incidence of
heart attack and stroke.
But there's good news. A few weeks ago at the 2012 meeting of the
European League Against Rheumatism (EULAR) in Berlin, researchers presented a paper showing a dramatic reduction in heart attacks in people taking anti-TNF medication, such as Enbrel, Humira and Remicade."
The rest of the post is here.
Comments
Andrew
Lack of exercise and an improper diet and can contribute to heart disease and result in obesity. According to the American Heart Association, obesity is a major risk for heart disease due to its ability to raise blood pressure (resulting in arteriosclerosis) as well as contributing to diabetes. Diabetes is a common cause of heart disease. In fact, according to the American Diabetes Association, two out of three people with diabetes die from either heart disease or stroke. Thanks.
hcg1234